Cargando…
The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis
BACKGROUND: In April 2009, the Chinese government launched Zero Markup Drug Policy (ZMDP) to adjust medical institutions' revenue and expenditure structures. OBJECTIVE: This study evaluated the impact of implementing ZMDP (as an intervention) on the drug costs for managing Parkinson's dise...
Autores principales: | Wang, Ruilin, Li, Xinya, Gu, Xinchun, Cai, Qian, Wang, Yayong, Yi, Zhan-Miao, Chen, Li-Chia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203530/ https://www.ncbi.nlm.nih.gov/pubmed/37228740 http://dx.doi.org/10.3389/fpubh.2023.1159119 |
Ejemplares similares
-
The impact of zero markup drug policy on patients' healthcare utilization and expense: An interrupted time series study
por: Zhu, Zheng, et al.
Publicado: (2022) -
Medical service pricing and pharmaceutical supply chain coordination contracts under the zero-markup drug policy
por: Zhou, Nan, et al.
Publicado: (2023) -
Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China
por: Peng, Zixuan, et al.
Publicado: (2021) -
Systematic Review of the Effect of a Zero-Markup Policy for Essential Drugs on Healthcare Costs and Utilization in China, 2015–2021
por: Liu, Wen-Yi, et al.
Publicado: (2021) -
The Financial Impact of the ‘Zero-Markup Policy for Essential Drugs’ on Patients in County Hospitals in Western Rural China
por: Zhou, Zhongliang, et al.
Publicado: (2015)